Merck & Co

News

Merck & Co to buy cancer biotech Peloton for $2.2bn

Merck & Co is to buy the privately-held biotech Peloton for up to $2.2 billion, adding further oncology drugs to its pipeline as it searches for successors to cancer blockbuster Keytrud

News

Merck & Co's Keytruda fails in triple negative breast cancer...

Most of the time, Merck & Co’s Keytruda (pembrolizumab) has been a consistent performer across a range of cancers – but it has produced an uncharacteristic failure in tough to treat tri

News

Keytruda drives another strong Merck quarter, but what’s nex...

Merck & Co/MSD’s first quarter followed the predictable pattern of a surge in sales on the back of immuno-oncology blockbuster Keytruda, but analysts are starting to ask how the company

News

Merck & Co pens $340m pain drug deal with KCL and Wellcome

Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers that could provide an alternative to opioids and their dangerous

News

KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called melanoma

Keytruda 100mg/4mL Vial and Carton
2015

Keytruda could get patient-friendly 6 week dosing schedule i...

US-based Merck & Co is putting further pressure on its arch-rival Bristol-Myers Squibb with a potential new six-week dosing schedule for some European patients taking its Keytruda (pemb

News

Pharma CEOs grilled by US Senators over drug prices

Pharma bosses faced a grilling from the US Senate’s Finance Committee over the high price of branded prescription drugs in the US compared with other developed countries.

Merck & Co to buy cancer biotech Peloton for $2.2bn

Merck & Co's Keytruda fails in triple negative breast cancer...

Keytruda drives another strong Merck quarter, but what’s nex...

Merck & Co pens $340m pain drug deal with KCL and Wellcome

Keytruda could get patient-friendly 6 week dosing schedule i...

Pharma CEOs grilled by US Senators over drug prices

ASH: AstraZeneca's dual-wielding CAR-T shows promise

How to meet your physicians where they are online

Merck &amp; Co

Editor's Picks

Merck & Co